New pill shows promise for Tough-to-Treat blood cancer

This study tests an experimental oral drug called HH2853 in about 100 people with peripheral T-cell lymphoma that has come back or not responded to prior treatments. The drug works by blocking certain proteins that help cancer cells grow. The goal is to see if it can shrink tumors and control the disease, though ongoing treatment is expected.